Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion type Assertion NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_head.
- NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion description "[The present study investigated CYP2C9 in regard to its allelic variants in 23 tumor samples (10 breast tumors, 1 breast tumor cell line, 5 brain tumors, 7 glioma cell lines) with restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_provenance.
- NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion evidence source_evidence_curated NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_provenance.
- NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion SIO_000772 16475710 NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_provenance.
- NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion wasDerivedFrom ctd_human-20150221 NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_provenance.
- NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_assertion wasGeneratedBy ECO_0000218 NP12180.RA56O8H5_T3FiGSIpH6fuJqnz41BxYya92OLe3tSIAuQM130_provenance.